This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Intel Corporation
Arrow Financial Corporation
Tonix Pharmaceuticals Holding Corp.
Castle Biosciences
Boost Run Inc. Class A
Intel Corporation INTC | 0.00 | |
Arrow Financial Corporation AROW | 0.00 | |
Tonix Pharmaceuticals Holding Corp. TNXP | 0.00 | |
Castle Biosciences CSTL | 0.00 | |
Boost Run Inc. Class A BRUN | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst James Schneider initiated coverage on Intel Corp (NASDAQ:INTC) with a Neutral rating and announced a price target of $150. Intel shares closed at $131.91 on Wednesday. See how other analysts view this stock.
- Keefe, Bruyette & Woods analyst Damon Delmonte initiated coverage on Arrow Financial Corp (NASDAQ:AROW) with a Market Perform rating and announced a price target of $42. Arrow Financial shares closed at $40.36 on Wednesday. See how other analysts view this stock.
- BTIG analyst Gregory Lewis initiated coverage on Boost Run Inc (NASDAQ:BRUN) with a Buy rating and announced a price target of $45. Boost Run shares closed at $34.26 on Wednesday. See how other analysts view this stock.
- Raymond James analyst Tiago Fauth initiated coverage on Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) with a Strong Buy rating and announced a price target of $26. Tonix Pharmaceuticals shares closed at $12.10 on Wednesday. See how other analysts view this stock.
- Roth Capital analyst Max Masucci initiated coverage on Castle Biosciences Inc (NASDAQ:CSTL) with a Buy rating and announced a price target of $40. Castle Biosciences shares closed at $22.12 on Wednesday. See how other analysts view this stock.
Considering buying TNXP stock? Here’s what analysts think:
Photo via Shutterstock